Annovis Bio, Inc. (ANVS) Form 8-K — May 20, 2026
$ANVSForm 8-KItems 1.01, 7.01, 9.01Filed May 20, 2026, 8:00 AM ET0001104659-26-064514Original filing
Annovis Bio, Inc. (ANVS) entered into an underwriting agreement with Canaccord Genuity LLC to sell 7,895,000 shares of common stock and accompanying warrants to purchase 7,105,500 shares in a public offering. The combined offering price is $1.90 per share and warrant package, generating gross proceeds of approximately $15 million for the company. The warrants are immediately exercisable at a price of $2.25 per share and expire six years from the date of issuance.
Key figures
- Gross Proceeds
- 15000000
- Offering Price
- 1.9
- Shares Offered
- 7895000
- Warrants Offered
- 7105500
- Warrant Exercise Price
- 2.25
- Warrant Expiration Years
- 6
Price after filing
1 day: +5.4%7 days: -1.5%30 days: -14.2%
Close on the filing date to close N calendar days later (from $2.04). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.